Kubica J, Adamski P, Gajda R, Kubica A, Ostrowska M, Casu G
Cardiol J. 2025; 32(1):83-89.
PMID: 39776051
PMC: 11870009.
DOI: 10.5603/cj.98323.
Mansouritorghabeh H, Monard A, Heubel-Moenen F, Leentjens J, Stroobants A, Henskens Y
Int J Lab Hematol. 2024; 47(2):201-211.
PMID: 39659111
PMC: 11885686.
DOI: 10.1111/ijlh.14403.
Adamski P, Adamska U, Buszko K, Sikora J, Czajkowski R
J Clin Med. 2024; 13(4).
PMID: 38398278
PMC: 10889129.
DOI: 10.3390/jcm13040965.
Kubica J, Adamski P, Dobrzycki S, Gajda R, Gasior M, Gierlotka M
Cardiol J. 2023; 31(1):133-146.
PMID: 37964649
PMC: 10919555.
DOI: 10.5603/cj.96076.
Feher G, Hargroves D, Illes Z, Klivenyi P, Liu L, Szapary L
Front Neurol. 2021; 12:762060.
PMID: 34650516
PMC: 8505968.
DOI: 10.3389/fneur.2021.762060.
Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers.
Buszko K, Kubica K, Hobl E, Adamski P, Wnuk K, Jilma B
Front Physiol. 2021; 12:663170.
PMID: 34248659
PMC: 8264498.
DOI: 10.3389/fphys.2021.663170.
Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor.
Adamski P, Buszko K, Sikora J, Niezgoda P, Fabiszak T, Ostrowska M
Sci Rep. 2019; 9(1):3924.
PMID: 30850677
PMC: 6408477.
DOI: 10.1038/s41598-019-40628-0.
Evaluation of platelet activity by multiple electrode impedance aggregometry in acute coronary syndromes: pilot study in a Brazilian tertiary-care public hospital.
De Lorenzo A, Dutra M, Mattos M, Rey H, Tibirica E
Braz J Med Biol Res. 2019; 52(2):e8001.
PMID: 30652826
PMC: 6328968.
DOI: 10.1590/1414-431X20188001.
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure.
Yi H, Hwang G, Hun Lee B
J Korean Neurosurg Soc. 2019; 62(1):3-9.
PMID: 30630291
PMC: 6328804.
DOI: 10.3340/jkns.2018.0151.
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
Borgognone A, Shantsila E, Worrall S, Prompunt E, Loka T, Loudon B
Cardiovasc Res. 2018; 114(10):1313-1323.
PMID: 29659727
PMC: 6054254.
DOI: 10.1093/cvr/cvy087.
Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients.
Bouida W, Beltaief K, Baccouche H, Sassi M, Dridi Z, Trabelsi I
PLoS One. 2018; 13(3):e0192590.
PMID: 29529091
PMC: 5846719.
DOI: 10.1371/journal.pone.0192590.
No-reflow and platelet reactivity in diabetic patients with ST-segment elevation myocardial infarction: is there a link?.
Kuliczkowski W, Miszalski-Jamka K, Kaczmarski J, Pres D, Gasior M
Postepy Kardiol Interwencyjnej. 2018; 13(4):326-330.
PMID: 29362576
PMC: 5770864.
DOI: 10.5114/aic.2017.71615.
Factors related to on-treatment platelet aggregation assessed by multiple electrode aggregometry in percutaneous coronary intervention patients on clopidogrel and aspirin.
Kukula K, Klopotowski M, Was J, WrOBel A, Jamiolkowski J, Debski A
Postepy Kardiol Interwencyjnej. 2017; 13(3):210-217.
PMID: 29056993
PMC: 5644039.
DOI: 10.5114/aic.2017.70188.
Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel.
Bouida W, Baccouche H, Sassi M, Dridi Z, Chakroun T, Hellara I
Thromb J. 2017; 15:15.
PMID: 28588426
PMC: 5457725.
DOI: 10.1186/s12959-017-0138-0.
Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome.
Kukula K, Klopotowski M, Kunicki P, Jamiolkowski J, Debski A, Bekta P
BMC Cardiovasc Disord. 2016; 16(1):252.
PMID: 27931181
PMC: 5146852.
DOI: 10.1186/s12872-016-0433-x.
Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease.
Li H, Guo J, Carlson G, Teng R
Br J Clin Pharmacol. 2016; 82(2):352-61.
PMID: 27038001
PMC: 4972151.
DOI: 10.1111/bcp.12950.
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
Kubica J, Adamski P, Ostrowska M, Sikora J, Kubica J, Sroka W
Eur Heart J. 2015; 37(3):245-52.
PMID: 26491112
PMC: 4712351.
DOI: 10.1093/eurheartj/ehv547.